PUBLIKATIONSREGISTRET

Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för tolfenamic acid. Visa hela publikationsregistret

Vad säger studierna?

Här kan du läsa sammanställningar från utvalda delar av forskningsartiklar. En enskild studie visar en del av bilden och ger inte i sig råd om att använda ett tillskott.

FORSKNINGSUTDRAG

Development and characterization of novel polyurethane films impregnated with tolfenamic acid for therapeutic applications. ↗

Istanbullu H, Ahmed S, Sheraz MA, Ihtesham ur Rehman.

Vad undersöktes?

Hur undersöktes det?
Ingen uppgift i sammanställningen
Vilka undersöktes?
Ingen uppgift i sammanställningen
Vilken ämnesform?
polyurethane (PU) films impregnated with a nonsteroidal anti-inflammatory drug, tolfenamic acid (TA)
Vilken mängd användes?
1 : 2 and 1 : 5 ratios
Hur länge pågick studien?
up to 3 months

Studieuppgifterna återges som originalcitat. Uppgifter som saknas här kan finnas i originalutdraget.

Vad kom studien fram till?

Författarna rapporterar att polyuretanfilmer impregnerade med tolfenaminsyra (TA) framställdes med lösningsmedelsevaporeringsteknik i två förhållanden (1:2 och 1:5) i tetrahydrofuran (THF) eller blandningar av THF-ethanol. XRD-studier visade en omvandling av kristallin TA till amorf form, där utsläppsprofilerna minskade från cirka 50 % till 25 % vid förhållandena 1:2 respektive 1:5. Metoden där både läkemedel och polymer löstes i THF var mer effektiv för att omvandla kristallin TA till amorf form jämfört med metoden där läkemedlet löstes i etanol.

Vad behöver resultatet vägas mot?

Underlaget omfattar endast utvalda artikelstycken; någon samlad bedömning kan inte göras.

Läs de originalstycken som sammanställningen bygger på
Abstract

The present study deals with the preparation of polyurethane (PU) films impregnated with a nonsteroidal anti-inflammatory drug, tolfenamic acid (TA). Solvent evaporation technique has been employed for the preparation of TA-PU films in two different ratios of 1 : 2 and 1 : 5 in Tetrahydrofuran (THF) or THF-ethanol mixtures. The prepared films were characterized using X-Ray Diffraction (XRD), Differential Scanning Calorimetry (DSC), Fourier Transform Infrared Spectroscopy (FTIR), Scanning Electron Microscopy (SEM), and release studies. The results indicate transformation of crystalline TA to its amorphous form. The degree of crystallinity changes both by increasing the polymer concentration and solvent used for the film preparations. The release profiles of TA were also found to be affected, showing a decrease from approximately 50% to 25% from 1 : 2 to 1 : 5 ratios, respectively.

3.1. Appearance of TA-PU Films

Equal volumes of the solutions were used in the preparation of all films. However, TA-PU films prepared by two different methods showed some differences in their appearance. The films prepared by method I (both drug and polymer in THF) were found to be more transparent with smooth surface whereas the films prepared by method II (drug in ethanol and polymer in THF) appeared opaque with slightly rough surface. No signs of recrystallization or changes in appearance took place in all the films during storage for up to 3 months in a desiccator.

3.2.1. XRD Studies

The pure crystalline TA shows characteristic diffraction peaks at 2θ values of 5.21°, 11.58°, 15.72°, 18.70°, 19.77°, 24.90°, 25.32°, 25.90°, and 26.81°, respectively (). In case of PU, a hallow diffraction pattern with no sharp peaks has been observed in the pure as well as in the control films thus indicating its amorphous nature. A typical diffraction pattern has been presented in . The diffraction patterns of the 1 : 2 TA-PU films prepared by method I indicated a marked decrease in the peaks intensity of the crystalline TA and show very small peaks at around 15.72–18.70° and 24.90–26.81° whereas the remaining peaks of the drug have not been detected (). The diffraction pattern of 1 : 5 TA-PU films also shows similar type of result with comparatively less intense peaks in the same region (). This decrease in peak intensity clearly indicates that majority of drug has been transformed to the amorphous form.

3.2.1. XRD Studies

The films prepared using ethanol for drug solubilisation (method II) showed similar type of diffraction patterns for 1 : 2 and 1 : 5 ratios, respectively, but the intensity of the peaks is comparatively higher to the films prepared in THF only (method I) (Figures and ). Therefore, method I could be considered as more effective comparatively in converting crystalline TA to its amorphous form. Similarly, the difference in the diffraction pattern of the films indicates that the solvent also plays an important role in modifying the solid state properties of the drug in addition to the technique used and the nature of the polymer. THF evaporates more rapidly as compared to ethanol-THF mixture [] and therefore the use of THF alone has resulted in greater amorphicity of the drug. The samples were further subjected to analysis by DSC, FTIR, and SEM techniques in order to confirm the results obtained by XRD.

Artikelns licens · ActiQs sammanfattningar och texturval är bearbetningar av källan.

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

23 träffar
Bibliografisk träff 2013-05-10

Toward the establishment of standardized in vitro tests for lipid-based formulations, part 3: understanding supersaturation versus precipitation potential during the in vitro digestion of type I, II, IIIA, IIIB and IV lipid-based formulations.

Williams HD, Sassene P, Kleberg K, Calderone M, Igonin A, Jule E, Vertommen J, Blundell R, Benameur H, Müllertz A, Pouton CW, Porter CJ, LFCS Consortium.

Pharm Res · research support, non-u.s. gov't; journal article · DOI 10.1007/s11095-013-1038-z